-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15.75196.61% Upside
Fennec Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Fennec Pharmaceuticals Inc.?
Fennec Pharmaceuticals Inc. has been rated by research analysts at Craig-Hallum, H.C. Wainwright, Cantor Fitzgerald, Wedbush in the past 90 days.